AI-based Clinical Trials Solution Providers Market Share

North American Market Forecast

The market in the North American region is estimated to witness the highest growth over the forecast period. Owing to increasing penetration of AI-based tools and increasing government initiatives for adoption in different medical projects in the region. The region also has a rising corporate investment in artificial intelligence (AI). This is expected to contribute to market growth in the coming years. For instance, between 2018 and 2020, government agencies in the United States spent USD 1.9 billion on AI-related service obligations. Also, many ai-based startups opening their market in this region. For instance, BullFrog AI is a U.S. based ai startup, that creates bfLEAR an ai platform that allows precision medicines.

APAC Market Statistics

Furthermore, the AI-based clinical trials solution providers market in Asia Pacific is also anticipated to hold the significant revenue share. This can be attributed owing to the increasing number of AI-based startups in the region. The region also has an increasing awareness of AI-based clinical trials. Owing to the growing demand for AI tools and supportive government programs that focuses on the implementation of AI in the healthcare sector. Thus, the Asia Pacific region is expected to see significant growth in this market.

Europe Market Forecast

In addition, the Europe region is anticipated to experience significant AI-based clinical trials solution providers market growth owing to the region's growing geriatric and target populations, the expansion of key players' geographic markets, and active participation from governmental and nonprofit organizations.